COMPANY

Regeneration Biomedical

HQ: Newport Beach, CA source · regenerationbiomedical.com ↗ · West Coast

Keywords: neurology neurodegenerative diseases Alzheimer's disease Alzheimer Disease RB-ADSC

Location: Newport Beach, CA · source · Oct 14, 2026

Profile checked Oct 10, 2026

Timeline

2026-10 Trial start Phase 2: Study of Intracerebroventricular Injections of Autologous Adipose-Derived Stem Cells (RB-ADSCs) in Participants With Mild-Moderate Alzheimer's Disease source ↗
2026-09 Trial start Phase 1: Repeat Intracerebroventricular Injections of RB-ADSC in Subjects Previously Treated in RBI Protocol RB-ADSC-02 source ↗
Aug 14, 2023 Trial start Phase 1: Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheimer's Disease source ↗

2028-09 (ESTIMATED) · Phase 1 · Repeat Intracerebroventricular Injections of RB-ADSC in Subjects Previously Treated in RBI Protocol RB-ADSC-02 · NCT07373067
2029-02 (ESTIMATED) · Phase 2 · Study of Intracerebroventricular Injections of Autologous Adipose-Derived Stem Cells (RB-ADSCs) in Participants With Mild-Moderate Alzheimer's Disease · NCT07205601

Estimated primary completion per ClinicalTrials.gov. Dates move.

Record	Title	Phase	Status	Start	Primary completion
NCT05667649	Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheimer's Disease	Phase 1	Completed	Aug 14, 2023	Jun 25, 2026 (actual)
NCT07373067	Repeat Intracerebroventricular Injections of RB-ADSC in Subjects Previously Treated in RBI Protocol RB-ADSC-02	Phase 1	Not yet recruiting	2026-09	2028-09 (estimated)
NCT07205601	Study of Intracerebroventricular Injections of Autologous Adipose-Derived Stem Cells (RB-ADSCs) in Participants With Mild-Moderate Alzheimer's Disease	Phase 2	Not yet recruiting	2026-10	2029-02 (estimated)